FI956310A0 - Stabiloidut farmaseuttiset peptidikoostumukset - Google Patents

Stabiloidut farmaseuttiset peptidikoostumukset

Info

Publication number
FI956310A0
FI956310A0 FI956310A FI956310A FI956310A0 FI 956310 A0 FI956310 A0 FI 956310A0 FI 956310 A FI956310 A FI 956310A FI 956310 A FI956310 A FI 956310A FI 956310 A0 FI956310 A0 FI 956310A0
Authority
FI
Finland
Prior art keywords
composition
buffer
disinfectant
peptide compositions
stabilized pharmaceutical
Prior art date
Application number
FI956310A
Other languages
English (en)
Swedish (sv)
Other versions
FI117544B (fi
FI956310A (fi
Inventor
Alan Harris
Birgitta Tennhammar-Ekman
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22185761&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI956310(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Ab filed Critical Ferring Ab
Publication of FI956310A publication Critical patent/FI956310A/fi
Publication of FI956310A0 publication Critical patent/FI956310A0/fi
Application granted granted Critical
Publication of FI117544B publication Critical patent/FI117544B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
FI956310A 1993-06-29 1995-12-28 Menetelmä stabiloitujen farmaseuttisten peptidikoostumusten valmistamiseksi FI117544B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/084,563 US5482931A (en) 1993-06-29 1993-06-29 Stabilized pharmaceutical peptide compositions
US8456393 1993-06-29
SE9400622 1994-02-23
PCT/SE1994/000622 WO1995001185A1 (en) 1993-06-29 1994-06-22 Stabilized pharmaceutical peptide compositions

Publications (3)

Publication Number Publication Date
FI956310A FI956310A (fi) 1995-12-28
FI956310A0 true FI956310A0 (fi) 1995-12-28
FI117544B FI117544B (fi) 2006-11-30

Family

ID=22185761

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956310A FI117544B (fi) 1993-06-29 1995-12-28 Menetelmä stabiloitujen farmaseuttisten peptidikoostumusten valmistamiseksi

Country Status (20)

Country Link
US (1) US5482931A (fi)
EP (1) EP0710122B1 (fi)
JP (1) JP3795520B2 (fi)
KR (1) KR100195323B1 (fi)
CN (1) CN1109558C (fi)
AT (1) ATE210462T1 (fi)
CA (1) CA2166296C (fi)
CZ (1) CZ283186B6 (fi)
DE (1) DE69429431T2 (fi)
DK (1) DK0710122T3 (fi)
ES (1) ES2168301T3 (fi)
FI (1) FI117544B (fi)
HK (1) HK1000903A1 (fi)
HU (1) HU220044B (fi)
NZ (1) NZ268441A (fi)
PL (1) PL184437B1 (fi)
PT (1) PT710122E (fi)
RU (1) RU2140281C1 (fi)
SK (1) SK281470B6 (fi)
WO (1) WO1995001185A1 (fi)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0710243T3 (da) * 1993-06-29 2000-10-16 Ferring Bv Syntese af cykliske peptider
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
GB9320232D0 (en) * 1993-10-01 1993-11-17 C V Lab Ltd Alginate wound dressing
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5916582A (en) * 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6979442B1 (en) 1998-08-17 2005-12-27 Pfizer Inc. Stabilized protein compositions
US6187332B1 (en) * 1999-06-14 2001-02-13 Wisconsin Alumni Research Foundation Acidic buffered nasal spray
CN1175901C (zh) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 一种稳定的干扰素水溶液
US6894026B1 (en) * 2000-01-11 2005-05-17 Atossa Healthcare, Inc. Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
EP1121935B1 (en) * 2000-02-04 2008-08-13 Patents Exploitation Company B.V. Pharmaceutical composition containing a small or medium size peptide
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003269747A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
WO2003097083A1 (fr) 2002-05-21 2003-11-27 Daiichi Suntory Pharma Co.,Ltd. Compositions medicinales contenant de la ghreline
US7812120B2 (en) * 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ATE301990T1 (de) 2003-07-25 2005-09-15 Ferring Bv Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
ES2260563T3 (es) * 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
JP4951344B2 (ja) 2004-08-24 2012-06-13 第一三共株式会社 生理活性ペプチド液状製剤
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
EP1814591A4 (en) * 2004-11-22 2009-04-22 Anadis Ltd BIOACTIVE PREPARATIONS
CN101137357B (zh) * 2005-03-10 2012-07-04 3M创新有限公司 含有羟基羧酸的酯的抗微生物组合物
TW200719884A (en) * 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
EP3025704B1 (en) * 2005-03-10 2019-01-16 3M Innovative Properties Company Methods of reducing microbial contamination
US20060293243A1 (en) * 2005-06-17 2006-12-28 Navneet Puri Stable, buffered, pharmaceutical compositions including motilin-like peptides
US20060287243A1 (en) * 2005-06-17 2006-12-21 Navneet Puri Stable pharmaceutical compositions including motilin-like peptides
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
US9023793B2 (en) 2006-09-29 2015-05-05 Retrophin, Inc. Intranasal carbetocin formulations and methods for the treatment of autism
US8338491B2 (en) 2006-10-27 2012-12-25 3M Innovative Properties Company Antimicrobial compositions
EP2167040A1 (en) * 2007-06-07 2010-03-31 MDRNA, Inc. Intranasal carbetocin formulations and methods for the treatment of autism
EP2197532A1 (en) 2007-08-06 2010-06-23 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
ES2596435T3 (es) * 2008-05-21 2017-01-09 Ferring B.V. Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nicturia
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
KR102059255B1 (ko) 2009-06-18 2019-12-24 세레니티 파마슈티컬즈 엘엘씨 안전한 데스모프레신 투여
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
CN102440957B (zh) * 2011-12-16 2013-09-25 深圳市健元医药科技有限公司 醋酸特利加压素鼻腔喷雾剂及其制备方法
CN103830720A (zh) * 2014-03-25 2014-06-04 深圳翰宇药业股份有限公司 一种含缩宫素的药物组合物
BR112017014545A2 (pt) 2015-01-07 2018-01-16 Trigemina Inc formulações de oxitocina que contém magnésio e métodos de uso
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) * 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
WO2019180561A1 (en) 2018-03-20 2019-09-26 Mankind Pharma Ltd. Stable pharmaceutical composition of vasopressin
CN112969449A (zh) * 2018-06-15 2021-06-15 费灵有限公司 特利加压素组合物及其用途
TW202034899A (zh) 2018-09-20 2020-10-01 克里斯托弗 Ｓ 布萊恩特 卡貝縮宮素藥品及其製備方法
TW202031283A (zh) 2018-09-20 2020-09-01 馬克 Ｃ 曼寧 穩定卡貝縮宮素鼻內製劑
CN113453661A (zh) * 2018-12-21 2021-09-28 艾瑞克有限公司 新组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB199922A (en) * 1922-05-29 1923-07-05 George Fargher Hight Improvements in door holders
GB1202607A (en) * 1968-01-10 1970-08-19 Novo Terapeutisk Labor As Improvements in or relating to stable glucagon solutions and their preparation
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
DE2254043C2 (de) * 1972-11-04 1985-01-24 Hoechst Ag, 6230 Frankfurt LH-Releasing Hormon zur nasalen Applikation
GB1454105A (en) * 1972-11-04 1976-10-27 Hoechst Ag Preparation containing luteinizing hormone-releasing factor
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
JPH0651637B2 (ja) * 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
PT84342B (pt) * 1986-02-25 1989-09-14 Smithkline Beecham Corp Processo de preparacao de compostos de vasopressina
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
JP2514249B2 (ja) * 1989-05-23 1996-07-10 帝人株式会社 安定化されたカルシトニン類医薬組成物
EP0432431B1 (en) * 1989-11-16 1993-06-16 PHIDEA S.p.A. Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient
JP2951681B2 (ja) * 1990-02-23 1999-09-20 株式会社資生堂 経粘膜投与用薬剤組成物
JPH0674209B2 (ja) * 1990-09-17 1994-09-21 旭化成工業株式会社 カルバ型カルシトニン類水溶液注射剤の安定化方法
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
PT708657E (pt) * 1993-06-29 2001-11-30 Ferring Bv Composicoes para administracao nasal de desmopressina

Also Published As

Publication number Publication date
EP0710122A1 (en) 1996-05-08
FI117544B (fi) 2006-11-30
FI956310A (fi) 1995-12-28
CA2166296C (en) 1998-06-23
CZ283186B6 (cs) 1998-01-14
CA2166296A1 (en) 1995-01-12
KR960703340A (ko) 1996-08-17
WO1995001185A1 (en) 1995-01-12
PL312203A1 (en) 1996-04-01
KR100195323B1 (ko) 1999-06-15
DE69429431D1 (de) 2002-01-24
HU9503842D0 (en) 1996-02-28
RU2140281C1 (ru) 1999-10-27
PT710122E (pt) 2002-05-31
DE69429431T2 (de) 2002-05-02
JP3795520B2 (ja) 2006-07-12
CN1126440A (zh) 1996-07-10
JPH09502424A (ja) 1997-03-11
PL184437B1 (pl) 2002-10-31
US5482931A (en) 1996-01-09
SK281470B6 (sk) 2001-04-09
EP0710122B1 (en) 2001-12-12
NZ268441A (en) 1996-09-25
HK1000903A1 (en) 2002-06-28
DK0710122T3 (da) 2002-03-11
SK165195A3 (en) 1997-02-05
ATE210462T1 (de) 2001-12-15
CZ339195A3 (en) 1997-01-15
ES2168301T3 (es) 2002-06-16
CN1109558C (zh) 2003-05-28
HU220044B (hu) 2001-10-28
HUT73775A (en) 1996-09-30

Similar Documents

Publication Publication Date Title
DK0710122T3 (da) Stabiliserede farmaceutiske peptidsammensætninger
LV10178A (lv) Fiziologiski saderigu glabajot stabilu cilveka olbaltumvielu preparatu iegusanas panemiens
HUP0000589A2 (hu) Vizes peptid készítmények
ES2062417T3 (es) Composiciones farmaceuticas de cimetidina.
DE69531314D1 (de) Verwendung von metallionen chelatoren zur stabilisierung von interferon-enthaltenden pharmazeutischen zubereitungen
IL114449A0 (en) Multiple unit tableted dosage form
ES2158898T3 (es) Composiciones para la administracion de desmopresina por via nasal.
PH23003A (en) Piroxicam monohydrate and aqueous pharmaceutical formulations containing same
CA2141964A1 (en) Pharmaceutical agents containing diphosphonic acids and salts thereof
ES2034326T3 (es) Composicion espermicida.
HU9303006D0 (en) Oral pharmaceutical composition

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117544

Country of ref document: FI

MA Patent expired